Journal of Clinical Endocrinology & Metabolism, Vol 59, 478-484, Copyright © 1984 by Endocrine Society

ARTICLES

Characterization of plasma and cerebrospinal fluid human angiotensinogen and des-angiotensin I-angiotensinogen by direct radioimmunoassay

C Genain, J Bouhnik, D Tewksbury, P Corvol and J Menard

Angiotensinogen and the product of its hydrolysis by renin, des- angiotensin I-angiotensinogen, were quantitated in human plasma and in cerebrospinal fluid (CSF) by a direct RIA. This assay was developed using polyclonal antibodies raised against pure human angiotensinogen. The antibodies recognized only primate angiotensinogen and des- angiotensin I-angiotensinogen. Results obtained with the direct RIA were compared with those of the indirect assay which measures angiotensinogen through angiotensin I liberated by an excess of renin. Both assays gave almost identical results in normal subjects whereas in three different conditions characterized by a high renin level (severe hypertension plus low sodium diet, converting enzyme inhibition, and adrenal insufficiency) higher results were obtained by the direct assay. This difference between the results of both methods was attributed to des-angiotensin I-angiotensinogen accumulation which is detected only in the direct assay. CSF angiotensinogen had similar immunochemical properties to plasma angiotensinogen and could also be measured by the direct RIA. Isoelectric focusing of plasma angiotensinogen and des-angiotensin I-angiotensinogen revealed a similar microheterogeneity. Microheterogeneity was also a characteristic of CSF angiotensinogen, but its isoelectric point was more basic than plasma angiotensinogen.

This article has been cited by other articles:

				M. Lacoste, Y. Cai, L. Guicharnaud, F. Mounier, Y. Dumez, R. Bouvier, F. Dijoud, M. Gonzales, J. Chatten, A.-L. Delezoide, et al. Renal Tubular Dysgenesis, a Not Uncommon Autosomal Recessive Disorder Leading to Oligohydramnios: Role of the Renin-Angiotensin System J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2253 - 2263. [Abstract] [Full Text] [PDF]

				M. Sherrod, X. Liu, X. Zhang, and C. D. Sigmund Nuclear localization of angiotensinogen in astrocytes Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R539 - R546. [Abstract] [Full Text] [PDF]

				J. Celerier, A. Cruz, N. Lamande, J.-M. Gasc, and P. Corvol Angiotensinogen and Its Cleaved Derivatives Inhibit Angiogenesis Hypertension, February 1, 2002; 39(2): 224 - 228. [Abstract] [Full Text] [PDF]

				E. Vila–Porcile, A. Barret, and P. Corvol Secretion of Renin-Angiotensin System (RAS) Components by Normal and Tumoral Lactotropes: A Comparative Study Using Reverse Hemolytic Plaque Assay (RHPA) and Immunoelectron Microscopy J. Histochem. Cytochem., December 1, 2000; 48(12): 1691 - 1704. [Abstract] [Full Text]

				J. Celerier, G. Schmid, J.-P. Le Caer, A.-P. Gimenez-Roqueplo, D. Bur, A. Friedlein, H. Langen, P. Corvol, and X. Jeunemaitre Characterization of a Human Angiotensinogen Cleaved in Its Reactive Center Loop by a Proteolytic Activity from Chinese Hamster Ovary Cells J. Biol. Chem., March 31, 2000; 275(14): 10648 - 10654. [Abstract] [Full Text] [PDF]

				A.-P. Gimenez-Roqueplo, J. Celerier, G. Schmid, P. Corvol, and X. Jeunemaitre Role of Cysteine Residues in Human Angiotensinogen. CYS232 IS REQUIRED FOR ANGIOTENSINOGEN-PRO MAJOR BASIC PROTEIN COMPLEX FORMATION J. Biol. Chem., December 18, 1998; 273(51): 34480 - 34487. [Abstract] [Full Text] [PDF]

				A.-P. Gimenez-Roqueplo, J. Celerier, G. Lucarelli, P. Corvol, and X. Jeunemaitre Role of N-Glycosylation in Human Angiotensinogen J. Biol. Chem., August 14, 1998; 273(33): 21232 - 21238. [Abstract] [Full Text] [PDF]

				P. Corvol and X. Jeunemaitre Molecular Genetics of Human Hypertension: Role of Angiotensinogen Endocr. Rev., October 1, 1997; 18(5): 662 - 677. [Abstract] [Full Text]

				J. Bohlender, J. Menard, F. C. Luft, and D. Ganten Dose Effects of Human Renin in Rats Transgenic for Human Angiotensinogen Hypertension, April 1, 1997; 29(4): 1031 - 1038. [Abstract] [Full Text]

				J. Bohlender, A. Fukamizu, A. Lippoldt, T. Nomura, R. Dietz, J. Menard, K. Murakami, F. C. Luft, and D. Ganten High Human Renin Hypertension in Transgenic Rats Hypertension, January 1, 1997; 29(1): 428 - 434. [Abstract] [Full Text] [PDF]

				J. Bohlender, J. Menard, J. Wagner, F. C. Luft, and D. Ganten Human Renin-Dependent Hypertension in Rats Transgenic for Human Angiotensinogen Hypertension, March 1, 1996; 27(3): 535 - 540. [Abstract] [Full Text]

				D. N. Muller, K. F. Hilgers, J. Bohlender, A. Lippoldt, J. Wagner, W. Fischli, D. Ganten, J. F. E. Mann, and F. C. Luft Effects of Human Renin in the Vasculature of Rats Transgenic for Human Angiotensinogen Hypertension, August 1, 1995; 26(2): 272 - 278. [Abstract] [Full Text]